Cytogenetics in the genomic era.
Chromosomal banding
DNA microarrays
Fluorescence in situ hybridization
Haematologic neoplasms
Leukaemia
Lymphoma
Next generation sequencing
Journal
Best practice & research. Clinical haematology
ISSN: 1532-1924
Titre abrégé: Best Pract Res Clin Haematol
Pays: Netherlands
ID NLM: 101120659
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
24
02
2020
revised:
30
04
2020
accepted:
27
05
2020
entrez:
11
10
2020
pubmed:
12
10
2020
medline:
8
10
2021
Statut:
ppublish
Résumé
Haematological neoplasms are characterised by the presence of recurrent chromosomal abnormalities, making cytogenetics essential for establishing the diagnosis and prognosis. Chromosome banding analysis is mandatory for chronic myeloid leukaemia, neoplasms with eosinophilia, myelodysplastic syndromes and acute leukaemias. In contrast, in other myeloid neoplasms, chronic lymphocytic leukaemia, non-Hodgkin lymphoma and multiple myeloma, the study must be complemented with fluorescence in situ hybridization and/or microarrays, which can overcome some of the shortcomings of banding analysis to identify potential cryptic alterations or reciprocal translocations. In the genomic era, novel technologies such as next generation sequencing are now being used in clinical routine analysis, since they offer the possibility of studying mutations and copy number alterations in a single study at a higher resolution and/or sensitivity. However, they require highly qualified staff and further standardisation, especially regarding data analysis, thereby limiting their current applicability.
Identifiants
pubmed: 33038985
pii: S1521-6926(20)30057-8
doi: 10.1016/j.beha.2020.101196
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101196Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.